Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dodwell

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
BMJ (Clinical Research Ed.)|August 27, 2025
Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort studyPaul McGale, David Dodwell, Andrew Challenger, et al.
Patient Education and Counseling|July 17, 2013
Shared understanding in psychiatrist-patient communication: association with treatment adherence in schizophreniaRosemarie McCabe, Patrick G T Healey, Stefan Priebe, et al.
BMJ Oncology|January 31, 2025
Treatment-related acute toxicity with adjuvant systemic treatment among patients with HER2-positive early invasive breast cancer: a national population-based cohort studyMelissa Ruth Gannon, David Dodwell, Katie Miller, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
Survival following adjuvant trastuzumab-based treatment among older patients with HER2-positive early invasive breast cancer: A national population-based cohort study using routine dataMelissa Ruth Gannon, David Dodwell, Katie Miller, et al.
Cancer Epidemiology|February 12, 2023
Concordance of cancer drug therapy information derived from routinely collected hospital admissions data and the Systemic Anti-Cancer Therapy (SACT) dataset, for older women diagnosed with early invasive breast cancer in EnglandMelissa Ruth Gannon, Min Hae Park, Katie Miller, et al.
BJS Open|July 8, 2024
Survival outcomes after breast cancer surgery among older women with early invasive breast cancer in England: population-based cohort studyKatie Miller, Melissa Ruth Gannon, Jibby Medina, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2025
Corrigendum to "Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage ovarian cancer: A retrospective cohort study" [Eur J Cancer 222 (2025) 115472]Luke Steventon, Shibani Nicum, Pinkie Chambers, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2025
Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage recurrent ovarian cancer: A retrospective cohort study in EnglandLuke Steventon, Shibani Nicum, Pinkie Chambers, et al.
Journal of Geriatric Oncology|November 2, 2023
Mastectomy patterns among older women with early invasive breast cancer in England and Wales: A population-based cohort studyKatie Miller, Melissa Ruth Gannon, Jibby Medina, et al.
Cancer Treatment Reviews|April 3, 2022
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortalityAmanda J Kerr, David Dodwell, Paul McGale, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
BMJ (Clinical Research Ed.)|August 27, 2025
Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort studyPaul McGale, David Dodwell, Andrew Challenger, et al.
Patient Education and Counseling|July 17, 2013
Shared understanding in psychiatrist-patient communication: association with treatment adherence in schizophreniaRosemarie McCabe, Patrick G T Healey, Stefan Priebe, et al.
BMJ Oncology|January 31, 2025
Treatment-related acute toxicity with adjuvant systemic treatment among patients with HER2-positive early invasive breast cancer: a national population-based cohort studyMelissa Ruth Gannon, David Dodwell, Katie Miller, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
Survival following adjuvant trastuzumab-based treatment among older patients with HER2-positive early invasive breast cancer: A national population-based cohort study using routine dataMelissa Ruth Gannon, David Dodwell, Katie Miller, et al.
Cancer Epidemiology|February 12, 2023
Concordance of cancer drug therapy information derived from routinely collected hospital admissions data and the Systemic Anti-Cancer Therapy (SACT) dataset, for older women diagnosed with early invasive breast cancer in EnglandMelissa Ruth Gannon, Min Hae Park, Katie Miller, et al.
BJS Open|July 8, 2024
Survival outcomes after breast cancer surgery among older women with early invasive breast cancer in England: population-based cohort studyKatie Miller, Melissa Ruth Gannon, Jibby Medina, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2025
Corrigendum to "Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage ovarian cancer: A retrospective cohort study" [Eur J Cancer 222 (2025) 115472]Luke Steventon, Shibani Nicum, Pinkie Chambers, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2025
Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage recurrent ovarian cancer: A retrospective cohort study in EnglandLuke Steventon, Shibani Nicum, Pinkie Chambers, et al.
Journal of Geriatric Oncology|November 2, 2023
Mastectomy patterns among older women with early invasive breast cancer in England and Wales: A population-based cohort studyKatie Miller, Melissa Ruth Gannon, Jibby Medina, et al.
Cancer Treatment Reviews|April 3, 2022
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortalityAmanda J Kerr, David Dodwell, Paul McGale, et al.
Pageof 12